CIK 0001878313 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- Open-market buys, last 90 days
- $352,317
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Guerrero Ramiro Director | Purchase | +73,333 | $1.50 | $110K | 534,885 |
| 2025-02-24 | Guerrero Ramiro Director | Purchase · Warrants | +73,333 | $1.87 | $137K | 73,333 |
| 2025-02-24 | Smith Stan Director | Purchase | +50,000 | $1.50 | $75K | 1,180,060 |
| 2025-02-24 | Smith Stan Director | Purchase · Warrants | +50,000 | $1.87 | $94K | 50,000 |
| 2025-02-10 | Gryaznov Sergei Chief Scientific Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2025-02-10 | Vitoc Vlad Chief Executive Officer | Grant or award · Stock Options | +400,000 | 400,000 | ||
| 2025-02-10 | Himmelreich Jeffrey C Head of Finance | Grant or award · Stock Options | +10,000 | 10,000 | ||
| 2024-12-31 | Luput Cristian Director | Grant or award · Stock Options | +10,225 | 10,225 | ||
| 2024-12-31 | Guerrero Ramiro Director | Grant or award · Stock Options | +10,225 | 10,225 | ||
| 2024-12-31 | Louie Ngar Yee Director | Grant or award · Stock Options | +15,338 | 15,338 | ||
| 2024-12-31 | Smith Stan Director | Grant or award · Stock Options | +12,782 | 12,782 | ||
| 2024-12-31 | CHAOUKI STEVEN M Director | Grant or award · Stock Options | +10,225 | 10,225 | ||
| 2024-12-31 | Theagene Jean-Manasse Director | Grant or award · Stock Options | +10,225 | 10,225 | ||
| 2024-12-13 | Smith Stan Director | Purchase | +25,000 | $1.87 | $47K | 1,130,060 |
| 2024-12-13 | Smith Stan Director | Purchase · Warrants | +25,000 | $2.08 | $52K | 25,000 |
| 2024-12-13 | Guerrero Ramiro Director | Purchase | +53,418 | $1.87 | $100K | 514,970 |
| 2024-12-13 | Guerrero Ramiro Director | Purchase · Warrants | +53,418 | $2.08 | $111K | 53,418 |
| 2024-11-05 | Vitoc Vlad Chief Executive Officer | Gift · Stock Options | −19,981 | $1.80 | $36K | 149,519 |
| 2024-11-05 | Vitoc Vlad Chief Executive Officer | Gift · Stock Options | +19,981 | $1.80 | $36K | 19,981 |
| 2024-11-05 | Vitoc Vlad Chief Executive Officer | Gift · Stock Options | −19,982 | $1.80 | $36K | 129,537 |
Page 6 of 7 · 140 trades